Systematic review and meta-analysis: Enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - A post hoc analysis from the Cochrane Collaboration

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 9, 2005, Pages 1055-1061

  Leontiadis, G I ^a   Sharma, V K ^b   Howden, C W ^c  

^a UNIVERSITY HOSPITAL OF NORTH DURHAM   (United Kingdom)

^b MAYO CLINIC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ASIA; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EUROPE; GEOGRAPHY; HUMAN; META ANALYSIS; MORTALITY; NORTH AMERICA; PEPTIC ULCER BLEEDING; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER HEMORRHAGE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 18444363643     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02441.x     Document Type: Review

References (32)

1. Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample. Rockville, MD, USA: Agency for Healthcare Research and Quality, 1997.
2. van Leerdam ME, Vreeburg EM, Rauws EAJ, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98: 1494-9.
3. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. Br Med J 2005; 330: 568-70.
4. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for peptic ulcer bleeding: an updated Cochrane Collaboration meta-analysis of randomized controlled trials. Gastroenterology 2005: 128 (in press).
5. Barkun A, Racz I, van Rensburg C, et al. Prevention of peptic ulcer rebleeding using continuous infusion of pantoparzole vs ranitidine: a multicenter, multinational, randomized, doubleblind, parallel-group comparison. Gastroenterology 2004; 126: A-78 (Abstract).
6. Jensen DM, Pace SC, Soffer EF, Mark ME, Comer GM. Lower rebleeding rates in high risk patients treated with IV pantoprazole than IV ranitidine after endoscopic hemostasis in a randomized controlled US study. Am J Gastroenterol 2004; 99: S296.
7. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper gastrointestinal tract: an open randomized controlled study. Digestion 1990; 45: 217-25.
8. Daneshmend TK, Hawkey CJ, Langman MJS, Logan RFA, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled study. Br Med J 1992; 304: 143-7.
9. Michel P, Duhamel C, Bazin B, et al. Lansoprazole versus ranitidine dans la prévention des récidives précoces des hémorragies digestives ulcéreuses gastro-duodénales. Gastroenterol Clin Biol 1994; 18: 1102-5.
10. Pérez Flores R, Garcia Molinero MJ, Herrero Quirós C, et al. Tratamiento de la hemorragia digestive alta de origen péptico: Ranitidina intravenosa versus Omeprazol intravenoso. Rev Esp Enferm Dig 1994; 86: 637-41.
11. Lanas A, Artal A, Bias JM, Arroyo MT. Lopez-Zaborras J, Sainz R. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol 1995; 21: 103-6.
12. Villanueva C, Balanzo J, Torras X, et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy 1995; 27: 308-12.
13. Cardi M, Muttillo IA, Amadori L, et al. Omeprazole versus ranitidine intraveineux dans le traitement de l'ulcere duodenal hemorragique: une etude randomisee prospective. Ann Chir 1997; 51: 136-9.
14. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997; 32: 328-33.
15. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 1997; 40: 36-41.
16. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 1997; 32: 320-7.
17. Coraggio F, Rotondano G, Marmo R, et al. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report. Eur J Gastroenterol Hepatol 1998; 10: 673-6.
18. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336: 1054-8.
19. Lin HJ, Lo WC, Perng CL, Wang K, Lee FY. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study. Hepatogastroenterology 1997; 44: 1495-9.
20. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998; 158: 54-8.
21. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 310-6.
22. Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111: 280-4.
23. Sheu BS, Chi CH, Huang CC, Kao AW, Wang YL, Yang HB. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment Pharmacol Ther 2002; 16: 137-43.
24. Kaviani MJ, Hashemi MR, Kazemifar AR, et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003; 17: 211-6.
25. Desprez D, Blank P, Bories JM, et al. Acute upper gastrointestinal hemorrhage: preliminary report of a randomized controlled trial comparing intravenous administration of ranitidine and omeprazole. Gastroenterology 1995; 108: 82 (Abstract).
26. Fried R, Beglinger C, Meier R, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gut 1999; 45 (Suppl. V): A100 (Abstract).
27. Duvnjak M, Supanc V, Troskot B, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in prevention of re-bleeding from gastroduodenal ulcers. Gut 2001; 49 (Suppl. III): 2379 (Abstract).
28. Lam SK, Hasan M, Sircus W, Wong J, Ong GB, Prescott RJ. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980; 21: 324-8.
29. van Herwaarden MA, Samson M, van Nispen CHM, Mulder PGH, Smout AJPM. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine. Aliment Pharmacol Ther 1999; 13: 731-40.
30. Caraco Y, Lagerstrom PO, Wood AJJ. Ethnic and genetic determinants of omeprazole disposition and effect. Clin Pharmacol Ther 1996; 60: 157-67.
31. Caraco Y, Wilkinson GR, Wood AJJ. Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole. Clin Pharmacol Ther 1996; 60: 396-404.
32. Khuroo MS, Khuroo MS, Farahat KLC, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol 2005; 20: 11-25.